AI MARKET SCANNING

Outlook Therapeutics Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +1.22%
MAX GAP RECORD +7.14%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $OTLK
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 14, 2026 Earnings Release 2026-08-14 (BEFORE OPEN)
-5.06%
May 15, 2026 Earnings Release 2026-05-15 (AFTER CLOSE)
+0.88%
Feb 17, 2026 Earnings Release 2026-02-17 (BEFORE OPEN)
+0.00%
Dec 19, 2025 Earnings Release 2025-12-19 (BEFORE OPEN)
-0.97%
Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE)
+2.88%
May 15, 2025 Earnings Release 2025-05-15 (AFTER CLOSE)
+1.49%
Feb 14, 2025 Earnings Release 2025-02-14 (BEFORE OPEN)
+2.17%
Dec 27, 2024 Earnings Release 2024-12-27 (BEFORE OPEN)
+6.47%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.9%
Bullish Gaps (7)
Bearish Gaps (2)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $OTLK

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-05 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1242m +27.63%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗